Initiative for quality in psoriasis and psoriatic arthritis

Wolf Henning Boehncke, Ade Adebajo, Alberto Cauli, Peter Nash, Carlo Salvarani, Arthur F. Kavanaugh

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Psoriasis is a common and severe skin disease. Up to 30% of psoriasis patients develop psoriatic arthritis (PsA), another severe disease that contributes significantly to the burden of psoriatic disease in patients. The treatment of patients with both psoriasis and PsA is particularly challenging, because different strategies are often followed, and considerable resources are needed for these chronic inflammatory diseases. Of note, psoriasis patients tend to be undertreated. Efforts to improve the management of psoriasis and PsA are urgently needed, to incorporate improvement of patient outcomes by promotion of best practice from both the medical and the pharmacoeconomic perspective. These are the goals of the Quality Movement in the USA and of quality management in general. The need for evidence-based guidance on safety, efficacy, overall outcome, and cost-effectiveness is being addressed by numerous initiatives striving to generate practice guidelines, control costs, and optimize cost-effectiveness of treatments. The 2007 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis's (GRAPPA) Initiative for Quality aims to secure and improve management of psoriasis and PsA, elaborating on these evidence-based guidelines by defining major domains of quality and creating a checklist that identifies physicians who can administer state-of-the-art medical services to patients who need their services.

Original languageEnglish
Pages (from-to)1431-1433
Number of pages3
JournalJournal of Rheumatology
Volume35
Issue number7
Publication statusPublished - Jul 2008

Fingerprint

Psoriatic Arthritis
Psoriasis
Practice Guidelines
Cost-Benefit Analysis
Pharmaceutical Economics
Cost Control
Checklist
Skin Diseases
Chronic Disease
Guidelines
Physicians
Safety
Therapeutics
Research

Keywords

  • Psoriasis
  • Psoriatic arthritis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Boehncke, W. H., Adebajo, A., Cauli, A., Nash, P., Salvarani, C., & Kavanaugh, A. F. (2008). Initiative for quality in psoriasis and psoriatic arthritis. Journal of Rheumatology, 35(7), 1431-1433.

Initiative for quality in psoriasis and psoriatic arthritis. / Boehncke, Wolf Henning; Adebajo, Ade; Cauli, Alberto; Nash, Peter; Salvarani, Carlo; Kavanaugh, Arthur F.

In: Journal of Rheumatology, Vol. 35, No. 7, 07.2008, p. 1431-1433.

Research output: Contribution to journalArticle

Boehncke, WH, Adebajo, A, Cauli, A, Nash, P, Salvarani, C & Kavanaugh, AF 2008, 'Initiative for quality in psoriasis and psoriatic arthritis', Journal of Rheumatology, vol. 35, no. 7, pp. 1431-1433.
Boehncke WH, Adebajo A, Cauli A, Nash P, Salvarani C, Kavanaugh AF. Initiative for quality in psoriasis and psoriatic arthritis. Journal of Rheumatology. 2008 Jul;35(7):1431-1433.
Boehncke, Wolf Henning ; Adebajo, Ade ; Cauli, Alberto ; Nash, Peter ; Salvarani, Carlo ; Kavanaugh, Arthur F. / Initiative for quality in psoriasis and psoriatic arthritis. In: Journal of Rheumatology. 2008 ; Vol. 35, No. 7. pp. 1431-1433.
@article{58ef26f0c5b444aca383b79837e13fdf,
title = "Initiative for quality in psoriasis and psoriatic arthritis",
abstract = "Psoriasis is a common and severe skin disease. Up to 30{\%} of psoriasis patients develop psoriatic arthritis (PsA), another severe disease that contributes significantly to the burden of psoriatic disease in patients. The treatment of patients with both psoriasis and PsA is particularly challenging, because different strategies are often followed, and considerable resources are needed for these chronic inflammatory diseases. Of note, psoriasis patients tend to be undertreated. Efforts to improve the management of psoriasis and PsA are urgently needed, to incorporate improvement of patient outcomes by promotion of best practice from both the medical and the pharmacoeconomic perspective. These are the goals of the Quality Movement in the USA and of quality management in general. The need for evidence-based guidance on safety, efficacy, overall outcome, and cost-effectiveness is being addressed by numerous initiatives striving to generate practice guidelines, control costs, and optimize cost-effectiveness of treatments. The 2007 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis's (GRAPPA) Initiative for Quality aims to secure and improve management of psoriasis and PsA, elaborating on these evidence-based guidelines by defining major domains of quality and creating a checklist that identifies physicians who can administer state-of-the-art medical services to patients who need their services.",
keywords = "Psoriasis, Psoriatic arthritis",
author = "Boehncke, {Wolf Henning} and Ade Adebajo and Alberto Cauli and Peter Nash and Carlo Salvarani and Kavanaugh, {Arthur F.}",
year = "2008",
month = "7",
language = "English",
volume = "35",
pages = "1431--1433",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "7",

}

TY - JOUR

T1 - Initiative for quality in psoriasis and psoriatic arthritis

AU - Boehncke, Wolf Henning

AU - Adebajo, Ade

AU - Cauli, Alberto

AU - Nash, Peter

AU - Salvarani, Carlo

AU - Kavanaugh, Arthur F.

PY - 2008/7

Y1 - 2008/7

N2 - Psoriasis is a common and severe skin disease. Up to 30% of psoriasis patients develop psoriatic arthritis (PsA), another severe disease that contributes significantly to the burden of psoriatic disease in patients. The treatment of patients with both psoriasis and PsA is particularly challenging, because different strategies are often followed, and considerable resources are needed for these chronic inflammatory diseases. Of note, psoriasis patients tend to be undertreated. Efforts to improve the management of psoriasis and PsA are urgently needed, to incorporate improvement of patient outcomes by promotion of best practice from both the medical and the pharmacoeconomic perspective. These are the goals of the Quality Movement in the USA and of quality management in general. The need for evidence-based guidance on safety, efficacy, overall outcome, and cost-effectiveness is being addressed by numerous initiatives striving to generate practice guidelines, control costs, and optimize cost-effectiveness of treatments. The 2007 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis's (GRAPPA) Initiative for Quality aims to secure and improve management of psoriasis and PsA, elaborating on these evidence-based guidelines by defining major domains of quality and creating a checklist that identifies physicians who can administer state-of-the-art medical services to patients who need their services.

AB - Psoriasis is a common and severe skin disease. Up to 30% of psoriasis patients develop psoriatic arthritis (PsA), another severe disease that contributes significantly to the burden of psoriatic disease in patients. The treatment of patients with both psoriasis and PsA is particularly challenging, because different strategies are often followed, and considerable resources are needed for these chronic inflammatory diseases. Of note, psoriasis patients tend to be undertreated. Efforts to improve the management of psoriasis and PsA are urgently needed, to incorporate improvement of patient outcomes by promotion of best practice from both the medical and the pharmacoeconomic perspective. These are the goals of the Quality Movement in the USA and of quality management in general. The need for evidence-based guidance on safety, efficacy, overall outcome, and cost-effectiveness is being addressed by numerous initiatives striving to generate practice guidelines, control costs, and optimize cost-effectiveness of treatments. The 2007 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis's (GRAPPA) Initiative for Quality aims to secure and improve management of psoriasis and PsA, elaborating on these evidence-based guidelines by defining major domains of quality and creating a checklist that identifies physicians who can administer state-of-the-art medical services to patients who need their services.

KW - Psoriasis

KW - Psoriatic arthritis

UR - http://www.scopus.com/inward/record.url?scp=47349123744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47349123744&partnerID=8YFLogxK

M3 - Article

C2 - 18609739

AN - SCOPUS:47349123744

VL - 35

SP - 1431

EP - 1433

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 7

ER -